Schneiderman Prelims Vol-I. qxd

CONGENITAL LESIONS
Sclerema neonatorum 
JAAD 45:325–361, 2001; Ped Derm
10:271–276, 1993
Smooth muscle hamartoma 
Ped Derm 13:222–225, 1996
DEGENERATIVE DISORDERS
Limb immobilization
DRUG-INDUCED LESIONS
Appetite suppressants – amphetamine, diethylpropion
J Rheumatol 11:254–255, 1984
Bleomycin – sclerodermatous changes of hands 
Clin
Rheumatol 18:422–424, 1999; JAAD 33:851–852, 1995;
J Rheumatol 19:294–296, 1992; AD 107:553–555, 1973
Bromocriptine – morphea 
Int J Dermatol 28:177–179, 1989
Carbidopa 
NEJM 303:782–787, 1980
Corticosteroids – distal phalangeal atrophy due to topical
steroid therapy 
AD 123:571–572, 1987
Diltiazem – thickened skin of the feet 
Int J Cardiol 35:115, 1992
Docataxel 
BJD 147:619–621, 2002; Cancer 88:1078–1081,
2000; Cancer 76:110–115, 1995
Ergot
Ethosuximide
Gemcitabine – edema of legs with subsequent sclerodermoid
changes 
JAAD 51:S73–76, 2004
Heparin, injected 
Ann DV 112:245–247, 1985 5-hydroxytryptophan
with carbidopa – eosinophilia-myalgia-like lesions 
NEJM
303:782–787, 1980
Interferon-
α
-induced eosinophilic fasciitis 
JAAD 37:118–120, 1997
Interferon-
β
1b
JAAD 37:553–558, 1997
Isoniazid
Meperidine
Methysergide 
BJD 153:224–225, 2005
Paclitaxel 
JAAD 48:279–281, 2003; BJD 147:619–621, 2002
Peplomycin (derivative of bleomycin)-induced scleroderma
BJD 1213–1214, 2004
D
-penicillamine 
BJD 116:95–100, 1987; morphea-like reaction
Ann Rheum Dis 40:42–44, 1981
Pentazocine (Talwin), injected – woody induration with overlying
ulceration 
AD 127:1591–1592, 1991; JAAD 22:694–695, 1990
Sodium valproate 
AD 116:621, 1980
Uracil-tegafur (UFT) 
JAAD 42:519–520, 2000
Vitamin K (fat soluble) (phytonadione) injection (Texier’s
syndrome) – sclerodermiform atrophic plaques
AD
137:957–962, 2001; JAAD 38:322–324, 1998; Cutis 61:81–83,
1998; Cutis 43:364–368, 1989; AD 121:1421–1423, 1985